Novo Tellus completes its transformative growth partnership with Grand Venture Technology

Grand Venture Technology embarks on the next chapter of global growth as Aalberts completes the privatisation of the company Novo Tellus, a leading private equity fund focused on building industrial and technology companies, is pleased to announce the successful completion of its investment in Grand Venture Technology (“GVT” or the “Company”). https://mma.prnewswire.com/media/2810329/Novo_Tellus_completes_transformative_growth_partnership_Grand_Venture_Technology.jpg Novo Tellus inaugurated […]

AbbVie Reports Third-Quarter 2025 Financial Results

— Reports Third-Quarter Diluted EPS of $0.10 on a GAAP Basis, a Decrease of 88.6 Percent; Adjusted Diluted EPS of $1.86, a Decrease of 38.0 Percent; These Results Include an Unfavorable Impact of $1.50 Per Share Related to Acquired IPR&D and Milestones Expense — Delivers Third-Quarter Net Revenues of $15.776 Billion, an Increase of 9.1

69% of consumers failed to reduce their debt last quarter, Achieve survey finds

Most consumer debt loads grew or remained level over the past three months as more households turn to credit cards to make ends meet Over one-in-four consumers (27%) took on more debt during the past three months, according to the results of the latest survey by Achieve, the leader in digital personal finance. The current

Equifax Announces Participation in November Investor Conferences

Equifax® (NYSE: EFX) will participate in two upcoming investor conferences in November. https://mma.prnewswire.com/media/448516/Equifax_jpg_Logo.jpg Mark Begor, Chief Executive Officer, and John Gamble, Chief Financial Officer, will participate in the J.P. Morgan Ultimate Services Investor Conference in New York on Tuesday, November 18, 2025, including participation in a Fireside Chat at 3:20 p.m., Eastern Time. The company

AtkinsRéalis appointed to 15-year nuclear decommissioning and waste framework with Sellafield Ltd.

AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world,has been appointed by Sellafield Ltd to a new framework delivering decommissioning activities for up to 15 years at one of Europe's largest and most complex nuclear sites. AtkinsRéalis has been appointed in two separate joint ventures to deliver

Customers Can Now Buy Pre-Owned Volkswagen Models in Raleigh, North Carolina

Prospective buyers interested in purchasing pre-owned Volkswagen models can visit Auction Direct USA in Raleigh, North Carolina, today. Car shoppers searching for a trusted name in quality pre-owned vehicles now have an exciting opportunity to explore an impressive range ofpre-owned Volkswagen models at Auction Direct USA. Known for their craftsmanship, advanced engineering and timeless design,

Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Stride, Inc. (LRN)

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy

(NASDAQ:CMND),(Frankfurt:CWY0), Vancouver, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the publication of a U.S. patent application expanding coverage of its non-hallucinogenic proprietary compound,

Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy

Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy GlobeNewswire October 31, 2025 Vancouver, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics

Knight-Swift Transportation Holdings Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – KNX

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Knight-Swift Transportation Holdings Inc. ("Knight-Swift Transportation Holdings Inc.") (NYSE:KNX) concerning possible violations of federal securities laws. On October 22, 2025, Knight-Swift published third quarter fiscal results for 2025. As part of the

Scroll to Top